McKesson 2014 Annual Report Download - page 6

McKESSON CORPORATION
3
PART I
Item 1. Business.
General
McKesson Corporation (“McKesson,” the “Company,” the “Registrant” or “we” and other similar pronouns), is a Fortune 14
corporation that delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer
while reducing costs.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this document
to a particular year shall mean the Company’s fiscal year.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act,”) are available free of charge on our website (www.mckesson.com under the “Investors — Financial Information — SEC
Filings” caption) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities
and Exchange Commission (“SEC” or the “Commission”). The content on any website referred to in this Annual Report on Form
10-K is not incorporated by reference into this report, unless expressly noted otherwise.
The public may also read or copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street,
N.E., Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the
SEC at 1-800-SEC-0330. The SEC maintains a website that contains reports, proxy and information statements, and other
information regarding issuers, including the Company, that file electronically with the SEC. The address of the website is
www.sec.gov.
Business Segments
We operate in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and
equipment and health and beauty care products throughout North America and internationally. This segment includes our
International pharmaceutical distribution and services business which reflects the results of operations from our acquisition of
Celesio AG (“Celesio”) in February 2014. This segment provides specialty pharmaceutical solutions for biotech and
pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and
other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution,
equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition,
this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting,
outsourcing and other services. In September 2013, we sold our 49% interest in Nadro, S.A. de C.V. (“Nadro”), a pharmaceutical
distributor in Mexico. Prior to the sale, financial results for Nadro were included in this segment.
The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes our InterQual® clinical
criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical,
patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other
services, including remote hosting and managed services, to healthcare organizations. This segment’s customers include hospitals,
physicians, homecare providers, retail pharmacies and payers primarily from North America.
Net revenues for our segments for the last three years were as follows:
Years Ended March 31,
(Dollars in billions) 2014 2013 2012
Distribution Solutions $ 134.4 98% $ 119.1 98% $ 119.4 98%
Technology Solutions 3.2 2% 3.0 2% 2.9 2%
Total $ 137.6 100% $ 122.1 100% $ 122.3 100%